ADRIAN ADAMS

Profile

First Name

: ADRIAN

Middle Name

:

Last Name

: ADAMS

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
ARALEZ PHARMACEUTICALS INC.
JENNIFER L. ARMSTRONG, JASON M. ARYEH, SCOTT J. CHARLES, NEAL F. FOWLER, MARK A. GLICKMAN, ROB HARRIS, ARTHUR S. KIRSCH, ANDREW I. KOVEN, KENNETH B. LEE JR., SETH A. RUDNICK, M.D., F. MARTIN THRASHER, ERIC L. TRACHTENBERG, JAMES P. TURSI, M.D.
DIRECTOR, EXECUTIVE OFFICER
IMPEL NEUROPHARMA INC
DAVID ALLISON, JON CONGLETON, MICHAEL HITE, MICHAEL P. HITE, RODNEY HO, JOHN D. HOEKMAN, JOHN LEAMAN, ROBERT MITTENDORFF, TIM NELSON, STEWART PARKER, AARON ROYSTON, ALI SATVAT, MAHENDRA SHAH, DIANE WILFONG, JIM YOUNG
DIRECTOR
ACELRX PHARMACEUTICALS INC
RICHARD AFABLE, VINCENT ANGOTTI, VINCENT J ANGOTTI, VINCENT J. ANGOTTI, RAFFI ASADORIAN, SHAKIL ASLAM, MARINA BOZILENKO, JILL BROADFOOT, ANIL DASU, BADRI DASU, BADRI N. DASU, BADRI P DASU, MARK EDWARDS, LARRY HAMEL, STEPHEN HOFFMAN, STEPHEN J HOFFMAN, STEPHEN J. HOFFMAN, ABHINAV JAIN, LINDA JUDGE, CARTER KING, RICHARD KING, HAMEL G. LAWRENCE, GUY NOHRA, PAMELA PALMER, PAMELA P PALMER, PAMELA P. PALMER, HOWARD ROSEN, HOWARD B ROSEN, HOWARD B. ROSEN, HOWIE ROSEN, THOMAS SCHRECK, THOMAS A SCHRECK, STEVE SULLIVAN, MARK WAN, MARK B WEEKS, JAMES WELCH, JAMES H. WELCH
DIRECTOR
TALPHERA, INC.
RICHARD AFABLE, VINCENT ANGOTTI, VINCENT J ANGOTTI, VINCENT J. ANGOTTI, RAFFI ASADORIAN, SHAKIL ASLAM, MARINA BOZILENKO, JILL BROADFOOT, ANIL DASU, BADRI DASU, BADRI N. DASU, BADRI P DASU, MARK EDWARDS, LARRY HAMEL, STEPHEN HOFFMAN, STEPHEN J HOFFMAN, STEPHEN J. HOFFMAN, ABHINAV JAIN, LINDA JUDGE, CARTER KING, RICHARD KING, HAMEL G. LAWRENCE, GUY NOHRA, PAMELA PALMER, PAMELA P PALMER, PAMELA P. PALMER, HOWARD ROSEN, HOWARD B ROSEN, HOWARD B. ROSEN, HOWIE ROSEN, THOMAS SCHRECK, THOMAS A SCHRECK, STEVE SULLIVAN, MARK WAN, MARK B WEEKS, JAMES WELCH, JAMES H. WELCH
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-09-10 
2025-04-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-04-02 
2024-01-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-01-22 
2023-07-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-17 
2022-08-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
2022-01-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-01-07 
2021-04-01
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-03-18 
2021-03-12
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-03-05 
2021-02-17
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-02-09 
2020-05-06
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-05-04 
2020-01-30
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-01-23 
2016-02-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Debt 
2016-02-05